| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30ed587317ad9a18467c0752dea305e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate |
2013-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ef9143bd59d7d493afcae3bf2fc5e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6730da303762b01f972c324bbabba46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7421c89394ce06f3b747adb2bb7bf591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e7d1c4a585a77f07974c9c282562282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_017cae077bcd051637404c6196d8c0fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_566155c11ab9711eb8b15f88b39caf99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e13d4c324f7a1d0e8f7d06c2b612f78 |
| publicationDate |
2018-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-354793-B |
| titleOfInvention |
METHODS TO PRODUCE ANAMORELINE CHLORHYDRATE THAT HAS CONTENT OF CONTROLLED CHLORIDE. |
| abstract |
The present invention relates to particulate forms of anamorelin monohydrochloride or a composition comprising anamorelin monohydrochloride having controlled chloride content, preferably isolated in an amorphous and / or fine particulate state, processes for making particulate forms and pharmaceutical compositions which They understand the particulate forms. |
| priorityDate |
2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |